Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00543_DB00615_nanopub.RAJMQT8XUhHniv6rpbxpH1hFQWFwJz-1uH8fTzDQaAhrU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00543_DB00615 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00543_DB00615 label "DDI between Amoxapine and Rifabutin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, amoxapine, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if rifabutin is initiated, discontinued or dose changed. [drugbank_resource:DB00543_DB00615]" assertion.
- drugbank_resource:DB00543_DB00615 identifier "drugbank_resource:DB00543_DB00615" assertion.
- drugbank_resource:DB00543_DB00615 title "DDI between Amoxapine and Rifabutin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, amoxapine, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amoxapine if rifabutin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00543 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00543_DB00615 assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00543_DB00615 assertion.